Welcome to our dedicated page for PACS Group news (Ticker: PACS), a resource for investors and traders seeking the latest updates and insights on PACS Group stock.
PACS Group, Inc. (NYSE: PACS) is a healthcare holding company focused on post-acute care, with independent subsidiaries that operate a large network of skilled nursing and other post-acute and senior living facilities across multiple U.S. states. The PACS news stream highlights how this platform evolves through acquisitions, financing decisions, regulatory developments, and operational milestones.
News about PACS Group frequently covers portfolio expansion, such as the acquisition of additional skilled nursing facilities in new or existing states, and updates on the total number of facilities and patients served. The company also issues releases on its use of an amended and restated credit facility, amendments and waivers under its credit agreement and master leases, and other capital structure matters that affect its ability to fund acquisitions, capital improvements, and working capital.
Because PACS is a public company in a regulated healthcare sector, its news often intersects with governance and compliance topics. Examples include announcements about restating certain previously issued financial statements, the completion of an independent Audit Committee investigation into third-party allegations, and actions taken to enhance regulatory compliance programs and internal controls. The company has also reported on NYSE listing status updates and extensions related to the timing of SEC filings.
Investors and observers can also find PACS news on leadership changes, such as appointments of compliance and human resources executives or interim finance leaders, as well as earnings releases, preliminary operating metrics, and conference presentations. For readers following PACS stock (PACS), this news feed provides a centralized view of the company’s operational performance, expansion activity, governance developments, and other events disclosed in press releases and related filings.
PACS Group, Inc. (NYSE: PACS) has announced an underwritten public offering of 13,888,890 shares of its common stock. The offering includes 2,777,778 shares sold by the company and 11,111,112 shares sold by certain selling stockholders. The selling stockholders may grant underwriters a 30-day option to purchase up to an additional 2,083,332 shares. PACS will not receive proceeds from the sale of shares by selling stockholders.
The offering is subject to market conditions, with no guarantee of completion or final terms. Citigroup, J.P. Morgan, and Truist Securities are lead book-running managers, while RBC Capital Markets, Goldman Sachs & Co. , and UBS Investment Bank are joint book-running managers. Stephens Inc. and Oppenheimer & Co. are co-managers.
PACS Group, Inc. (NYSE: PACS), a major post-acute healthcare company in the US, reported its Q2 2024 results. Key highlights include:
- Consolidated GAAP revenue for H1 2024 was $1.9 billion, up 31% year-over-year
- Q2 2024 revenue was $981.8 million, a 29% increase from Q2 2023
- Adjusted EBITDA for H1 2024 and Q2 2024 were $188.2 million and $99.7 million respectively
- Total Facilities occupancy was 91.0% in Q2 2024
- The company increased its 2024 full-year guidance, expecting revenue between $3.85-$3.95 billion and Adjusted EBITDA of $370-$380 million
PACS added 32 facilities and made 12 real estate acquisitions in the 12 months ending June 30, 2024, expanding its portfolio to 248 healthcare operations across 13 states.
PACS Group (NYSE: PACS) has announced it will release its second quarter 2024 financial results after market close on Monday, August 12, 2024. The company will host a conference call at 5:00 p.m. Eastern Time on the same day to discuss the results and related information. Investors can access the call via webcast on the PACS Group website or by dialing in. A recording of the call will be available for replay on the website for 30 days following the event. PACS Group encourages investors to monitor their press releases, SEC filings, public conference calls, webcasts, and website for important company information.
PACS Group announced that its subsidiaries will acquire operations of 53 skilled nursing and assisted/independent living facilities in the Pacific Northwest.
The facilities, currently operated by Prestige, are spread across 8 states, including Oregon (21), Washington (19), Idaho (6), Nevada (3), and one each in Alaska, Arizona, California, and Montana, with a total of 2,511 skilled nursing beds and 1,334 assisted living units.
PACS will lease 37 facilities from a joint venture where it holds a 25% interest, while the remaining 16 will be leased from third-party landlords.
The acquisition is expected to close in Q3 2024, subject to regulatory approvals and consents. The upfront capital required includes $15 million for the real estate joint venture.
PACS leadership expressed excitement about integrating these facilities and expanding their footprint to 5 new states.
PACS Group, one of the largest post-acute healthcare companies in the U.S., announced its Q1 2024 results. The company reported a net income of $49.1 million, a 30.7% increase from the previous year, and GAAP earnings per share of $0.38, up 31%. Revenue for the quarter rose by 31.9% to $934.7 million.
Adjusted EBITDA was $88.5 million, a 34% increase, and Adjusted EBITDAR reached $152.5 million. Total facilities occupancy was 91.1%, with notable increases in ramping and mature facilities. The company added 10 operating facilities, enhancing its portfolio to 218 healthcare operations.
CEO Jason Murray highlighted the importance of clinical excellence and CFO Derick Apt noted significant revenue growth from adding 5,194 beds. PACS projects 2024 revenue between $3.65 billion and $3.75 billion, with Adjusted EBITDA between $351 million and $361 million.
PACS Group, Inc. (NYSE: PACS) will announce its first quarter 2024 financial results on May 13, 2024, with a call on May 14, 2024, to discuss the results. The company operates over 200 post-acute care facilities in the US, serving 22,000 patients daily. Investors can access important information on the PACS Group website.
Summary not available.
Summary not available.